New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Biktarvy bictegravir/ emtricitabine/tenofovir alafenamide Click here for more information |
Gilead Sciences | A combination drug for treatment of HIV-1 infection. |
|
Erleada apalutamide Click here for more information |
Janssen | An androgen receptor inhibitor for non-metastatic, castration-resistant prostate cancer. |
|
Ilumya tildrakizumab-asmn Click here for more information |
Merck | An interleukin-23 antagonist for moderate-to-severe plaque psoriasis. |
|
Lutathera lutetium Lu 177 dotatate Click here for more information |
Advanced Accelerator Applic. | A radiopharmaceutical for gastroenteropancreatic neuroendocrine tumors. |
|
Symdeko tezacaftor/ivacaftor Click here for more information |
Vertex Pharm. | A combination formulation for cystic fibrosis in patients with a specific gene mutation. |
|
Trogarzo ibalizumab-uiyk Click here for more information |
Thera Technologies | An antiretroviral for patients with multidrug resistant HIV-1 infection. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Apadaz benzhydrocodone/acetaminophen Click here for more information |
KemPharm | New combination formulation for short-term management of acute pain. |
|
Cimduo lamivudine/tenofovir disoproxil fumarate Click here for more information |
Mylan | New combination formulation for HIV-1 infection. |
|
Dexycu dexamethasone Click here for more information |
Icon Bioscience | New intraocular suspension formulation for postoperative inflammation. |
|
Firvanq vancomycin |
CurtisPharma | An oral solution formulation for C. difficile-associated diarrhea and enterocolitis caused by S. aureus (including MRSA). |
|
Osmolex ER amantadine Click here for more information |
Vertical Pharm. | New extended-release tablet formulation. |
|
Symfi efavirenz/lamivudine/tenofovir disoproxil fumarate Click here for more information |
Mylan | New combination formulation for HIV-1 infection. Contains a higher strength of efavirenz/tablet vs Symfi Lo. |
|
Symfi Lo efavirenz/lamivudine/tenofovir disoproxil fumarate Click here for more information |
Mylan | New combination formulation for HIV-1 infection. |
|
Ztlido lidocaine Click here for more information |
Scilex Pharm. | New topical patch formulation for post-herpetic neuralgia pain. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Zinbryta Daclizumab Click here for more information |
Biogen/AbbVie | The manufacturer is removing the drug from the worldwide market due to safety concerns, including reports of severe liver damage and immune-related conditions. |